Thirty-five mature male rabbits of mixed breeding were obtained locally for these experiments.
Animals were judged to be sexually mature when their testicular weights were estimated by palpation to be greater than 2 g. The animals were housed indoors at about 23°C under narural photoperiod. Food and water were provided ad libitum.
The rabbits were anesthetized with sodium pentobarbital (Abbott, 30 mg/kg) intravenously via the marginal ear vein, with ether supplementation.
The animals were restrained on an operating board and the scrotal sac was opened. The exposed gonad was ligated to stop blood flow, excised, and suspended in oxygenated Tyrodc solution (35°C) in an all-glass muscle warmer @O-ml ~01). Contractions were monitored isometrically with a Statham myograph transducer and a Gilson minipolygraph, as previously described (23). For in vivo preparations, the contralateral testis was exposed and threads were attached to the anterior and posterior tunica. The testis was drawn into a second muscle warmer and the inferior thread was secured to a hook on the bottom of the apparatus.
The scrotal sac was then secured around the base of the muscle warmer with a copper wire. Contractions were recorded as described for the in vitro preparation.
Pharmacological agents were added with micropipettes directly to the bathing medium.
Stirring tonus increases in response to high doses of PGFaLY in vivo (Fig. 121) . It prevented PGFzcY--induced stimulation of the testicular capsule in vitro in a noncompetitive manner. As concentrations of PGEI were increased above 7 X 1Od8 M (Fig. 2B) , capsular tonus increased after PGFB, treatment diminished and were abolished at a PGEI concentration of 1.4 X 1O-7 M. Figure 3C depicts the control LDR curve for epinephrine in vitro; the LDR curve for norepinephrine was also determined but did not difier significantly from that for epinephrine (P > 0.10; data not shown). 10m8 or 1.4 X 10mg M PG& (Fig. 3, A and B, respectively) markedly potentiated the epinephrine-induced tonus increase of in vitro testicular capsules. Higher concentrations of PGEI, however, noncompetitively inhibited epinephrineinduced tonus increases at all concentrations tested and increased the threshold for stimulation (Fig. 3, D and E).
At 7 X 10F7 M PGEI, the maximum average stimulation by epinephrine was reduced to less than 30 % of the control value. However, PGFZ, (10-7-10-6 M) did not reduce epinephrine stimulation in vitro or in vivo (data not shown). Figure 4 -B depicts the tonus increases after epinephrine treatment in vivo as an LDR curve. At 1.4 X IOh M PGEI potentiated the response of the capsule to epinephrine in vivo as well as in vitro (Fig. 4A) . As with the in vitro preparation, higher concentrations of PG& inhibited the testis and increased the amount of epinephrine required to stimulate the capsule (Fig. 4 , C and 0) I At 7 X 1 Om7 M, PGEI reduced the average maximum tonus increase induced by epinephrine to about 20 % of the control value; in the presence of this concentration of PGEI, two of the five preparations studied gave no response to epinephrine. Epinephrine's efficacy in stimulating the capsule in vitro exceeded that of either PGEI or acetylcholine (Fig* 5 ). Higher concentrations of PGEI became progressively less stimulatory to isolated, rinsed preparations; acetylcholine alone had no effect on such units in contrast to its stimulation of the testis in vivo (Fig. 5, B and C) . Peak efficacies in vivo followed the order: epinephrine = PGFzQl = 2.0 PGEl = 4.4 acetylcholine.
According to the LDR curve for epinephrine in vitro (Fig. 3C) , high er doses became slightly less stimulatory (P < 0.05). Theophylline (0.1 mM), a phosphodiesterase inhibitor, reduced epinephrine stimulation to 60 % of the control value (compare Fig. 6 , 23 and C). However, the beta-adrenergic blocking agent propranolol not only restored but also increased the response of the capsule to a given dose of epinephrine in the presence of theophylline (Fig* 6A ).
DISCUSSION
The general potentiating effect of PGs at very low concentrations on contractions of smooth muscle induced by agents such as epinephrine, acetylcholine, and calcium was noticed early (6, 8) . This phenomenon was attributed to increased calcium entry into the cell (6). Indeed, not only do prostaglandins depend on calcium for their stimulation of the rabbit testicular capsule, but a reciprocal dependency exists, since high calcium concentrations (4-12 mM) have no effect on capsular tonus in vitro unless a stimulating agent such as PG, epinephrine, or histamine is present (11 thesized in rat and rabbit testes (4, 10, 13), such potentiation may occur naturally. In addition, Seeley (22) h as recently shown by thin-layer chromatography and bioassay that material resembling authentic PGE1, Ez, Fla, and Fzc, is released into bathing media from rabbit testes in vitro and in vivo. He estimated the levels of these compounds in vitro to be 1.42, 4.6, 0.25, and 0.20 nM, respectively. Extractions of whole rabbit testes for PGs, followed by chromatography and bioassay, gave estimates of 9.1 X 10p4, 3.8 X 10V, 0.27, and 0.14 pg/g tissue. Experiments are being conducted to determine any possible effects of the PG synthetase inhibitor indomethacin on capsular contractions in vivo. The bimodal effect of PGEl (or possibly its metabolites), which leads to inhibition at higher doses, correlates well with the observation of Clegg (5), who showed that low concentrations of PGEI potentiate, whereas high doses inhibit, the response of guinea pig seminal vesicles to catecholamines.
In addition, it agrees with the bronchiodilator and vasodilator (26) 
